J Cardiovasc Thorac Res. 2014;6(3): 197-202. doi: 10.15171/jcvtr.2014.011
PMID: 25320669        PMCID: PMC4195972

Original Article

Safety and Efficacy of Caproamin Fides and Tranexamic Acid Versus Placebo in Patients Undergoing Coronary Artery Revascularization


Cited by CrossRef: 2


1- Yates J, Perelman I, Khair S, Taylor J, Lampron J, Tinmouth A, Saidenberg E. Exclusion criteria and adverse events in perioperative trials of tranexamic acid: a systematic review and meta-analysis. Transfusion. 2018; [Crossref]
2- Kozek-Langenecker S, Ahmed A, Afshari A, Albaladejo P, Aldecoa C, Barauskas G, De Robertis E, Faraoni D, Filipescu D, Fries D, Haas T, Jacob M, Lanc√© M, Pitarch J, Mallett S, Meier J, Molnar Z, Rahe-Meyer N, Samama C, Stensballe J, Van der Linden P, Wikkels√ł A, Wouters P, Wyffels P, Zacharowski K. Management of severe perioperative bleeding. European Journal of Anaesthesiology. 2017;34(6):332 [Crossref]
3- Watanabe J, Ohtori S, Orita S, Yamauchi K, Eguchi Y, Aoki Y, Nakamura J, Suzuki M, Inage K, Sato J, Shiga Y, Abe K, Fujimoto K, Kanamoto H, Hanaoka E, Takahashi K. Efficacy of TachoSil, a Fibrin-Based Hemostat, for Anterior Lumbar Spine Surgery. Asian Spine J. 2016;10(5):930 [Crossref]